Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.99B |
| 2 |
Eli Lilly
LLY
|
+$3.22B |
| 3 |
UnitedHealth
UNH
|
+$2.21B |
| 4 |
Amazon
AMZN
|
+$2.17B |
| 5 |
Applied Materials
AMAT
|
+$1.87B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$6.48B |
| 2 |
Boeing
BA
|
+$4.34B |
| 3 |
Royal Caribbean
RCL
|
+$2.21B |
| 4 |
Broadcom
AVGO
|
+$1.17B |
| 5 |
Thermo Fisher Scientific
TMO
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Consumer Discretionary | 12.86% |
| 3 | Healthcare | 12.73% |
| 4 | Industrials | 10.59% |
| 5 | Financials | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Steven Madden
SHOO
$3.46B
| $91.1M | 0.02% |
2,720,354
+334,058
| +14% | +$9.36M |
|
302
Vista Energy
VIST
$7.33B
| $90.9M | 0.02% |
2,642,249
-20,349
| -0.8% | -$842K |
|
303
Bio-Techne
TECH
$11.2B
| $90.4M | 0.02% |
1,625,502
+619,552
| +62% | +$33.2M |
|
304
Vale
VALE
$58.7B
| $88.4M | 0.02% |
8,142,345
+42,928
| +0.5% | +$438K |
|
305
Alaska Air
ALK
$5.3B
| $84.6M | 0.02% |
1,700,000
| – | – |
|
306
Applied Industrial Technologies
AIT
$13.2B
| $84.5M | 0.02% |
323,793
-11,829
| -4% | -$3.1M |
|
|
APO.PRA
307
DELISTED
Apollo Global Management Series A
APO.PRA
| $83.8M | 0.02% |
1,192,174
| – | – |
|
308
Lowe's Companies
LOW
$122B
| $83.4M | 0.02% |
331,910
+2,238
| +0.7% | +$550K |
|
309
Boot Barn
BOOT
$4.92B
| $82.9M | 0.02% |
500,112
-17,895
| -3% | -$3.08M |
|
310
Wolfspeed
WOLF
$1.64B
| $79.4M | 0.01% |
+2,777,120
| New | +$6.51M |
|
311
Insight Enterprises
NSIT
$4.6B
| $79.3M | 0.01% |
699,550
-88,413
| -11% | -$11.5M |
|
312
State Street
STT
$52.2B
| $79.1M | 0.01% |
681,940
| – | – |
|
313
Southern Company
SO
$107B
| $78.2M | 0.01% |
824,760
+366
| +0% | +$34.2K |
|
314
Essent Group
ESNT
$6.23B
| $78M | 0.01% |
1,227,199
+3,006
| +0.2% | +$183K |
|
315
GSK
GSK
$101B
| $77.4M | 0.01% |
1,794,427
+17,615
| +1% | +$688K |
|
316
Encompass Health
EHC
$12.2B
| $76.5M | 0.01% |
602,521
-41,712
| -6% | -$4.97M |
|
317
First Advantage
FA
$3.81B
| $75.1M | 0.01% |
4,880,860
-163,702
| -3% | -$2.71M |
|
|
REVG
318
DELISTED
REV Group
REVG
| $73.3M | 0.01% |
1,294,033
-1,109,939
| -46% | -$58.9M |
|
319
e.l.f. Beauty
ELF
$5.43B
| $72.4M | 0.01% |
546,232
+57,241
| +12% | +$7.06M |
|
320
Sempra
SRE
$56.5B
| $72M | 0.01% |
800,000
-14
| -0% | -$1.13K |
|
321
Klaviyo
KVYO
$5.47B
| $71.8M | 0.01% |
2,593,143
-125,724
| -5% | -$4.06M |
|
322
Kymera Therapeutics
KYMR
$9.51B
| $71.4M | 0.01% |
1,262,182
| – | – |
|
323
Elastic
ESTC
$8.94B
| $70.5M | 0.01% |
833,950
+5,407
| +0.7% | +$455K |
|
324
Denali Therapeutics
DNLI
$3.97B
| $69.1M | 0.01% |
4,760,858
+10,279
| +0.2% | +$148K |
|
325
Marathon Digital Holdings
MARA
$3.56B
| $68.1M | 0.01% |
+3,728,896
| New | +$62.8M |
|
Similar funds
Capital Research Global Investors's Q3 2025 Portfolio in Review
As of Q3 2025, Capital Research Global Investors held 458 positions worth $533B, up 6.7% from $499B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Capital Research Global Investors's Q3 2025 filing shows 30 new, 198 increased, 163 reduced and 25 closed positions. Its largest new stake was Corning: 11,058,929 shares worth $907M. The largest sale was Meta Platforms (Facebook), an estimated $6.48B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Capital Research Global Investors's largest Q3 2025 buy was Corning: 11,058,929 shares worth $907M.
- Capital Research Global Investors added most to NVIDIA in Q3 2025, an estimated $3.99B increase.
- Capital Research Global Investors's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $6.48B.
- Capital Research Global Investors fully exited Ansys in Q3 2025, selling an estimated $984M.
- Capital Research Global Investors's ten largest holdings make up 38% of its $533B portfolio in Q3 2025.
- Capital Research Global Investors opened 30 new positions and closed 25 in Q3 2025.
- Capital Research Global Investors's portfolio value rose 6.7% quarter-over-quarter to $533B.
Based on Capital Research Global Investors's 13F filing for Q3 2025, filed 13 Nov 2025.